EPISODE · Feb 10, 2024 · 28 MIN
Exploring Microbiome-Based Therapy
from Let's Talk ID
Host Paul Sax, MD, FIDSA, is joined by Libby Hohmann, MD, FIDSA, an ID specialist at Massachusetts General Hospital, director of the Fecal Microbiota Transplant Lab and associate professor of medicine at Harvard Medical School, to discuss the innovative field of microbiome-based therapy, including the latest therapeutics, efficacy in treating COVID-19 and advice on treating patients with C. diff.
Embed this episode
Ready to play
Exploring Microbiome-Based Therapy
0:00
28:03
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Let's Talk ID?
This episode is 28 minutes long.
When was this Let's Talk ID episode published?
This episode was published on February 10, 2024.
Is there a transcript available for this episode?
Yes, a full transcript is available for this episode. You can read the complete transcript on the episode page.
Can I download this Let's Talk ID episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!